Relationship between mutations in HIV-1 RNase H domain and nucleoside reverse transcriptase inhibitors resistance mutations in experienced patients

被引：0
|
作者：
Marcelin, A [1 ]
Roquebert, B [1 ]
Malet, I [1 ]
Wirden, M [1 ]
Simon, A [1 ]
Katlama, C [1 ]
Calvez, V [1 ]
机构：
[1] Hop La Pitie Salpetriere, Dept Virol, Paris, France
来源：
ANTIVIRAL THERAPY | 2005年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S98 / S98
页数：1
相关论文
共 50 条
  • [1] Relationship between mutations in HIV-1 RNase H domain and nucleoside reverse transcriptase inhibitors resistance mutations in experienced patients
    Marcelin, AG
    Roquebert, B
    Malet, I
    Wirden, M
    Simon, A
    Katlama, C
    Calvez, V
    ANTIVIRAL THERAPY, 2005, 10 (04) : S98 - S98
  • [2] Relationship between mutations in HIV-1 RNase H domain and nucleoside reverse transcriptase inhibitors resistance mutations in naive and pre-treated HIV infected patients
    Roquebert, Benedicte
    Wirden, Marc
    Simon, Anne
    Deval, Jerome
    Katlama, Christine
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (03) : 207 - 211
  • [3] Mutations in the reverse transcriptase connection and RNase H domains exhibit dual resistance to nucleoside and non-nucleoside reverse transcriptase inhibitors
    Nikolenko, G. N.
    Delviks-Frankenberry, K. A.
    Jere, A.
    Pathak, V. K.
    ANTIVIRAL THERAPY, 2008, 13 (04) : A55 - A55
  • [4] Impact of unreported HIV-1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non-nucleoside inhibitors
    Saracino, A
    Monno, L
    Scudeller, L
    Cibelli, DC
    Tartaglia, A
    Punzi, G
    Torti, C
    Lo Caputo, S
    Mazotta, F
    Scotto, G
    Carosi, G
    Angarano, G
    JOURNAL OF MEDICAL VIROLOGY, 2006, 78 (01) : 9 - 17
  • [5] Identification of insertion mutations in HIV-1 reverse transcriptase causing multiple drug resistance to nucleoside analogue reverse transcriptase inhibitors
    Sugiura, W
    Matsuda, M
    Matsuda, Z
    Abumi, H
    Okano, A
    Oishi, T
    Moriya, K
    Yamamoto, T
    Fukutake, K
    Mimaya, J
    Ajisawa, A
    Taki, M
    Yamada, K
    Nagai, Y
    JOURNAL OF HUMAN VIROLOGY, 1999, 2 (03) : 146 - 153
  • [6] Selection of resistance-conferring mutations in HIV-1 by the nucleoside reverse transcriptase inhibitors (+/-)dOTC and (+/-)dOTFC
    Richard, N
    Salomon, H
    Oliveira, M
    Rando, R
    Mansour, T
    Gu, ZX
    Wainberg, MA
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 2000, 11 (06): : 359 - 365
  • [7] HIV-1 reverse transcriptase mutations found in a drug-experienced patient confer reduced susceptibility to multiple nucleoside reverse transcriptase inhibitors
    Fitzgibbon, JE
    DiCola, MB
    Arnold, E
    Das, K
    Sha, BE
    Pottage, JC
    Nahass, R
    Gaur, S
    John, JF
    ANTIVIRAL THERAPY, 2001, 6 (04) : 231 - 238
  • [8] Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors
    Harrigan, PR
    Mo, T
    Wynhoven, B
    Hirsch, J
    Brumme, Z
    McKenna, P
    Pattery, T
    Vingerhoets, J
    Bacheler, LT
    AIDS, 2005, 19 (06) : 549 - 554
  • [9] Mutations in the RNase H domain of HIV-1 reverse transcriptase affect the initiation of DNA synthesis and the specificity of RNase H cleavage in vivo
    Julias, JG
    McWilliams, MJ
    Sarafianos, SG
    Arnold, E
    Hughes, SH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (14) : 9515 - 9520
  • [10] Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors
    Gonzales, MJ
    Wu, TD
    Taylor, J
    Belitskaya, F
    Kantor, R
    Israelski, D
    Chou, S
    Zolopa, AR
    Fessel, WJ
    Shafer, RW
    AIDS, 2003, 17 (06) : 791 - 799
12345